Cargando…
260 Breast Cancer Biopsy Triage with Ex-Vivo Microscopy for Downstream Analysis
OBJECTIVES/GOALS: In this study, the ability of a pathologist to detect malignancy on digital pseudo-H&E slides obtained via structured illumination microscopy (SIM) imaging of fresh diagnostic breast biopsies was assessed. The speed of imaging and processing was also assessed for potential clin...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129547/ http://dx.doi.org/10.1017/cts.2023.322 |
_version_ | 1785030766750597120 |
---|---|
author | Behr, Madeline Roberts, Brett Alizadeh, Layla Brown, J. Quincy |
author_facet | Behr, Madeline Roberts, Brett Alizadeh, Layla Brown, J. Quincy |
author_sort | Behr, Madeline |
collection | PubMed |
description | OBJECTIVES/GOALS: In this study, the ability of a pathologist to detect malignancy on digital pseudo-H&E slides obtained via structured illumination microscopy (SIM) imaging of fresh diagnostic breast biopsies was assessed. The speed of imaging and processing was also assessed for potential clinical implementation. METHODS/STUDY POPULATION: This study was conducted in accordance with an Ochsner Medical Center of New Orleans IRB. 200 patients undergoing either stereotactic or ultrasound-guided diagnostic breast biopsies were consented and an additional core from the suspicious lesion was collected for research use. Research biopsies were transported to the lab and stained with DRAQ5 and Eosin-Y and imaged with SIM before being submitted for histology processing. Imaging and digital processing times were recorded. The resulting SIM images and histology slides were given to a pathologist for blind review to assess accuracy. RESULTS/ANTICIPATED RESULTS: The ex-vivo structured illumination microscopy images and subsequent histology slides from 79 research cores have been assessed to date. Some samples were excluded from the total data set and not included in the final assessment due to technical failures of the imaging protocol. Of the current set, the pathologist has a specificity of 88% and a sensitivity of 65%, as well as an NPV of 88% and a PPV of 65%. Staining time for each biopsy was completed within 3 and a half minutes and imaging at 20x magnification took between 4 and 12 minutes, depending on size and implementation of autofocus to the imaging system. Image processing took approximately 5 minutes per biopsy and is a direct function of biopsy size. DISCUSSION/SIGNIFICANCE: Decreased time between cancer suspicion and treatment will improve the prognosis of breast cancer patients. SIM imaging of fresh breast biopsies could ultimately allow primary and secondary histology to be performed simultaneously and minimize histopathology time, thus allowing clinicians and patients to implement treatment course more quickly. |
format | Online Article Text |
id | pubmed-10129547 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-101295472023-04-26 260 Breast Cancer Biopsy Triage with Ex-Vivo Microscopy for Downstream Analysis Behr, Madeline Roberts, Brett Alizadeh, Layla Brown, J. Quincy J Clin Transl Sci Precision Medicine/Health OBJECTIVES/GOALS: In this study, the ability of a pathologist to detect malignancy on digital pseudo-H&E slides obtained via structured illumination microscopy (SIM) imaging of fresh diagnostic breast biopsies was assessed. The speed of imaging and processing was also assessed for potential clinical implementation. METHODS/STUDY POPULATION: This study was conducted in accordance with an Ochsner Medical Center of New Orleans IRB. 200 patients undergoing either stereotactic or ultrasound-guided diagnostic breast biopsies were consented and an additional core from the suspicious lesion was collected for research use. Research biopsies were transported to the lab and stained with DRAQ5 and Eosin-Y and imaged with SIM before being submitted for histology processing. Imaging and digital processing times were recorded. The resulting SIM images and histology slides were given to a pathologist for blind review to assess accuracy. RESULTS/ANTICIPATED RESULTS: The ex-vivo structured illumination microscopy images and subsequent histology slides from 79 research cores have been assessed to date. Some samples were excluded from the total data set and not included in the final assessment due to technical failures of the imaging protocol. Of the current set, the pathologist has a specificity of 88% and a sensitivity of 65%, as well as an NPV of 88% and a PPV of 65%. Staining time for each biopsy was completed within 3 and a half minutes and imaging at 20x magnification took between 4 and 12 minutes, depending on size and implementation of autofocus to the imaging system. Image processing took approximately 5 minutes per biopsy and is a direct function of biopsy size. DISCUSSION/SIGNIFICANCE: Decreased time between cancer suspicion and treatment will improve the prognosis of breast cancer patients. SIM imaging of fresh breast biopsies could ultimately allow primary and secondary histology to be performed simultaneously and minimize histopathology time, thus allowing clinicians and patients to implement treatment course more quickly. Cambridge University Press 2023-04-24 /pmc/articles/PMC10129547/ http://dx.doi.org/10.1017/cts.2023.322 Text en © The Association for Clinical and Translational Science 2023 https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work. |
spellingShingle | Precision Medicine/Health Behr, Madeline Roberts, Brett Alizadeh, Layla Brown, J. Quincy 260 Breast Cancer Biopsy Triage with Ex-Vivo Microscopy for Downstream Analysis |
title | 260 Breast Cancer Biopsy Triage with Ex-Vivo Microscopy for Downstream Analysis |
title_full | 260 Breast Cancer Biopsy Triage with Ex-Vivo Microscopy for Downstream Analysis |
title_fullStr | 260 Breast Cancer Biopsy Triage with Ex-Vivo Microscopy for Downstream Analysis |
title_full_unstemmed | 260 Breast Cancer Biopsy Triage with Ex-Vivo Microscopy for Downstream Analysis |
title_short | 260 Breast Cancer Biopsy Triage with Ex-Vivo Microscopy for Downstream Analysis |
title_sort | 260 breast cancer biopsy triage with ex-vivo microscopy for downstream analysis |
topic | Precision Medicine/Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129547/ http://dx.doi.org/10.1017/cts.2023.322 |
work_keys_str_mv | AT behrmadeline 260breastcancerbiopsytriagewithexvivomicroscopyfordownstreamanalysis AT robertsbrett 260breastcancerbiopsytriagewithexvivomicroscopyfordownstreamanalysis AT alizadehlayla 260breastcancerbiopsytriagewithexvivomicroscopyfordownstreamanalysis AT brownjquincy 260breastcancerbiopsytriagewithexvivomicroscopyfordownstreamanalysis |